Preparation of a Monoclonal Antibody Against Amantadine and Rimantadine and Development of an Indirect Competitive Enzyme-Linked Immunosorbent Assay for Detecting the Same in Chicken Muscle and Liver.

Dapeng Peng,Wei,Yuanhu Pan,Yulian Wang,Dongmei Chen,Zhenli Liu,Xu Wang,Menghong Dai,Zonghui Yuan
DOI: https://doi.org/10.1016/j.jpba.2016.11.009
IF: 3.571
2016-01-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:A monoclonal antibody (mAb) was produced in order to monitor the illegal use of amantadine and rimantadine in animals. The produced mAb 2G3 exhibited an IC50 value of 15.8μgL-1 for amantadine and exhibited cross-reactivity to both amantadine (100%) and rimantadine (70.6%). Standard curves ranged from 5 to 80μgL-1 for 2G3. The limits of detection of the developed indirect competitive enzyme-linked immunosorbent assay (ic-ELISA) ranged from 5.0μgkg-1 to 5.4μgkg-1 in chicken muscle and liver. The recoveries were 81.3% to 98.1% with a coefficient of variation less than 15.7%. Good correlations were observed between the results of the ic-ELISA and liquid chromatography-mass spectrometry in the incurred tissues. These results suggest that ic-ELISA is a sensitive, accurate, and low-cost method that could be a useful tool for screening the residues of amantadine and rimantadine in chicken muscle and liver.
What problem does this paper attempt to address?